English

Biostar Pharmaceuticals, Inc.

EDGAR

Quarterly report (10-Q) · filed 2017-11-20

41 filing records in this dataset, filed from 2008-08-14 to 2017-11-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2017 Q3 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-1.41 thousand USD

2017 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 4585547 USD Source
Operating Cash Flow: 4586956 USD Source

Free cash flow

-45.8 thousand USD

2017 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 4585547 USD Source
Operating Cash Flow: 4586956 USD Source
Capital Expenditure: 4408070 USD Source
Capital Expenditure: 4363687 USD Source

Cash and cash equivalents: 365 thousand USD 2017-09-30 Source
Exact value

364973 USD
Long-term debt including current maturities: Not available
Shares outstanding: 2.64 million shares 2017-09-30 Source
Exact value

2637188 shares

Reported share-count change

19.28% · 426 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2210913 shares · 2016-09-30· Source
2637188 shares · 2017-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

318 thousand USD

2016-10-01 – 2017-09-30

Exact inputs and evidence

Revenue: 2384492 USD · 2016-01-01 – 2016-12-31 Source
Revenue: 2066698 USD · 2016-01-01 – 2016-09-30 Source
Revenue: 0 USD · 2017-01-01 – 2017-03-31 Source
Revenue: 0 USD · 2017-04-01 – 2017-06-30 Source
Revenue: 0 USD · 2017-07-01 – 2017-09-30 Source

Net income

934 thousand USD

2016-10-01 – 2017-09-30

Exact inputs and evidence

Net income: -5698385 USD · 2016-01-01 – 2016-12-31 Source
Net income: -9086460 USD · 2016-01-01 – 2016-09-30 Source
Net income: -1014150 USD · 2017-01-01 – 2017-03-31 Source
Net income: -1314387 USD · 2017-04-01 – 2017-06-30 Source
Net income: -125186 USD · 2017-07-01 – 2017-09-30 Source

Operating cash flow

8.59 million USD

2016-10-01 – 2017-09-30

Exact inputs and evidence

Operating cash flow: 4912665 USD · 2016-01-01 – 2016-12-31 Source
Operating cash flow: 911057 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: 321129 USD · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 4586956 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 321129 USD · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 4585547 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 4586956 USD · 2017-01-01 – 2017-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-11-20.

Financial data available through: 2016-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2016-12-31
Operating income: 10 of 11 periods available· newest 2016-12-31
Net income: 10 of 11 periods available· newest 2016-12-31
Operating cash flow: 10 of 11 periods available· newest 2016-12-31
Capital expenditure: 10 of 11 periods available· newest 2016-12-31
Total assets: 10 of 11 periods available· newest 2016-12-31
Total liabilities: 1 of 11 periods available· newest 2013-12-31
Current assets: 10 of 11 periods available· newest 2016-12-31
Current liabilities: 10 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2016-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-91.2%

Prior period

USD 27.13 million

2015-01-01 – 2015-12-31
Current period

USD 2.38 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

2384492 − 27129609 = -24745117 USD

27129609 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
2384492 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Year-over-year change in Revenue: -24745117 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2384492 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#121025 Filing: 000118518517000916 Input fundies:Revenue: 27129609 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#121153 Filing: 000118518517000916
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 19.41 million

Prior period

−USD 25.11 million

2015-01-01 – 2015-12-31
Current period

−USD 5.7 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-5698385 − -25112562 = 19414177 USD

-25112562 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-5698385 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Year-over-year change in Net income: 19414177 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -5698385 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#127184 Filing: 000118518517000916 Input fundies:NetIncome: -25112562 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#127309 Filing: 000118518517000916
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-16.4%

Prior period

USD 5.88 million

2015-01-01 – 2015-12-31
Current period

USD 4.91 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

4912665 − 5877213 = -964548 USD

5877213 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
4912665 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Year-over-year change in Operating cash flow: -964548 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 4912665 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#137878 Filing: 000118518517000916 Input fundies:OperatingCashFlow: 5877213 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138060 Filing: 000118518517000916
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 59,475

2015-01-01 – 2015-12-31
Current period

USD 0

2016-01-01 – 2016-12-31

Exact inputs and evidence

0 − 59475 = -59475 USD

59475 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
0 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Year-over-year change in Capital expenditure: -59475 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138242 Filing: 000118518517000916 Input fundies:CapitalExpenditure: 59475 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138418 Filing: 000118518517000916
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 2.38 million 100% of revenue
Cost of revenue USD 1.47 million 62% of revenue
Operating expenses USD 4.48 million 188% of revenue
Operating income −USD 3.56 million −149% of revenue
Tax, interest and other Derived USD 2.13 million 90% of revenue
Net income −USD 5.7 million −239% of revenue

Cash

Operating cash flow USD 4.91 million 206% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived USD 4.91 million 206% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 25%69%
2008 20%77%
2009 20%72%
2010 22%71%
2011 13%80%
2012 Operating loss: operating costs were 144% of revenue.
2013 Net income was higher than operating income, so the split is not drawn.
2014 Operating loss: operating costs were 102% of revenue.
2015 Operating loss: operating costs were 188% of revenue.
2016 Operating loss: operating costs were 249% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2007-01-01 – 2007-12-31	15887486	11041723 Derived	4845763	882239 Derived	3963524	1224150 Derived	Source 2007-01-01 – 2007-12-31: 15887486 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 4845763 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 3963524 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 1310489 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 86339 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	33910922	26149280 Derived	7761642	1071100 Derived	6690542	2041436 Derived	Source 2008-01-01 – 2008-12-31: 33910922 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 7761642 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 6690542 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 2093206 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 51770 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	53318744	38217901 Derived	15100843	4603003 Derived	10497840	5656948 Derived	Source 2009-01-01 – 2009-12-31: 53318744 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 15100843 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 10497840 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 5673509 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 16561 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	80214873	56604599 Derived	23610274	6228714 Derived	17381560	11374946 Derived	Source 2010-01-01 – 2010-12-31: 80214873 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 23610274 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 17381560 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 12841432 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 1466486 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	91965505	73806451 Derived	18159054	5985541 Derived	12173513	8662662 Derived	Source 2011-01-01 – 2011-12-31: 91965505 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 18159054 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 12173513 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 8773247 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 110585 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	49317844	71103904 Derived	-21786060	-1788737 Derived	-19997323	-3616564 Derived	Source 2012-01-01 – 2012-12-31: 49317844 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -21786060 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -19997323 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -3583694 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 32870 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	52729054	52220833 Derived	508221	-300825 Derived	809046	7927101 Derived	Source 2013-01-01 – 2013-12-31: 52729054 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 508221 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 809046 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 8909113 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 982012 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	61416587	62729282 Derived	-1312695	-6160907 Derived	4848212	441414 Derived	Source 2014-01-01 – 2014-12-31: 61416587 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -1312695 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 4848212 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 3310618 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 2869204 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	27129609	50887173 Derived	-23757564	1354998 Derived	-25112562	5817738 Derived	Source 2015-01-01 – 2015-12-31: 27129609 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -23757564 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -25112562 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 5877213 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 59475 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	2384492	5948754 Derived	-3564262	2134123 Derived	-5698385	4912665 Derived	Source 2016-01-01 – 2016-12-31: 2384492 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -3564262 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -5698385 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 4912665 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.4M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Revenue	15887486	Revenue: 15887486 Open source
20082008-12-31	Revenue	33910922	Revenue: 33910922 Open source
20092009-12-31	Revenue	53318744	Revenue: 53318744 Open source
20102010-12-31	Revenue	80214873	Revenue: 80214873 Open source
20112011-12-31	Revenue	91965505	Revenue: 91965505 Open source
20122012-12-31	Revenue	49317844	Revenue: 49317844 Open source
20132013-12-31	Revenue	52729054	Revenue: 52729054 Open source
20142014-12-31	Revenue	61416587	Revenue: 61416587 Open source
20152015-12-31	Revenue	27129609	Revenue: 27129609 Open source
20162016-12-31	Revenue	2384492	Revenue: 2384492 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-91.2% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Year over year	No prior comparable period	Revenue: 15887486 Open source
20082008-12-31	Year over year	113.4%	Revenue: 33910922 Open source Revenue: 15887486 Open source
20092009-12-31	Year over year	57.2%	Revenue: 53318744 Open source Revenue: 33910922 Open source
20102010-12-31	Year over year	50.4%	Revenue: 80214873 Open source Revenue: 53318744 Open source
20112011-12-31	Year over year	14.6%	Revenue: 91965505 Open source Revenue: 80214873 Open source
20122012-12-31	Year over year	-46.4%	Revenue: 49317844 Open source Revenue: 91965505 Open source
20132013-12-31	Year over year	6.9%	Revenue: 52729054 Open source Revenue: 49317844 Open source
20142014-12-31	Year over year	16.5%	Revenue: 61416587 Open source Revenue: 52729054 Open source
20152015-12-31	Year over year	-55.8%	Revenue: 27129609 Open source Revenue: 61416587 Open source
20162016-12-31	Year over year	-91.2%	Revenue: 2384492 Open source Revenue: 27129609 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -149.5% 2016

Net margin -239% 2016

Free cash flow margin 206% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Operating margin	30.5%	Operating Income: 4845763 Open source Revenue: 15887486 Open source
20082008-12-31	Operating margin	22.9%	Operating Income: 7761642 Open source Revenue: 33910922 Open source
20092009-12-31	Operating margin	28.3%	Operating Income: 15100843 Open source Revenue: 53318744 Open source
20102010-12-31	Operating margin	29.4%	Operating Income: 23610274 Open source Revenue: 80214873 Open source
20112011-12-31	Operating margin	19.7%	Operating Income: 18159054 Open source Revenue: 91965505 Open source
20122012-12-31	Operating margin	-44.2%	Operating Income: -21786060 Open source Revenue: 49317844 Open source
20132013-12-31	Operating margin	1%	Operating Income: 508221 Open source Revenue: 52729054 Open source
20142014-12-31	Operating margin	-2.1%	Operating Income: -1312695 Open source Revenue: 61416587 Open source
20152015-12-31	Operating margin	-87.6%	Operating Income: -23757564 Open source Revenue: 27129609 Open source
20162016-12-31	Operating margin	-149.5%	Operating Income: -3564262 Open source Revenue: 2384492 Open source
20072007-12-31	Net margin	24.9%	Net Income: 3963524 Open source Revenue: 15887486 Open source
20082008-12-31	Net margin	19.7%	Net Income: 6690542 Open source Revenue: 33910922 Open source
20092009-12-31	Net margin	19.7%	Net Income: 10497840 Open source Revenue: 53318744 Open source
20102010-12-31	Net margin	21.7%	Net Income: 17381560 Open source Revenue: 80214873 Open source
20112011-12-31	Net margin	13.2%	Net Income: 12173513 Open source Revenue: 91965505 Open source
20122012-12-31	Net margin	-40.5%	Net Income: -19997323 Open source Revenue: 49317844 Open source
20132013-12-31	Net margin	1.5%	Net Income: 809046 Open source Revenue: 52729054 Open source
20142014-12-31	Net margin	7.9%	Net Income: 4848212 Open source Revenue: 61416587 Open source
20152015-12-31	Net margin	-92.6%	Net Income: -25112562 Open source Revenue: 27129609 Open source
20162016-12-31	Net margin	-239%	Net Income: -5698385 Open source Revenue: 2384492 Open source
20072007-12-31	Free cash flow margin	7.7%	Revenue: 15887486 Open source Operating Cash Flow: 1310489 Open source Capital Expenditure: 86339 Open source
20082008-12-31	Free cash flow margin	6%	Revenue: 33910922 Open source Operating Cash Flow: 2093206 Open source Capital Expenditure: 51770 Open source
20092009-12-31	Free cash flow margin	10.6%	Revenue: 53318744 Open source Operating Cash Flow: 5673509 Open source Capital Expenditure: 16561 Open source
20102010-12-31	Free cash flow margin	14.2%	Revenue: 80214873 Open source Operating Cash Flow: 12841432 Open source Capital Expenditure: 1466486 Open source
20112011-12-31	Free cash flow margin	9.4%	Revenue: 91965505 Open source Operating Cash Flow: 8773247 Open source Capital Expenditure: 110585 Open source
20122012-12-31	Free cash flow margin	-7.3%	Revenue: 49317844 Open source Operating Cash Flow: -3583694 Open source Capital Expenditure: 32870 Open source
20132013-12-31	Free cash flow margin	15%	Revenue: 52729054 Open source Operating Cash Flow: 8909113 Open source Capital Expenditure: 982012 Open source
20142014-12-31	Free cash flow margin	0.7%	Revenue: 61416587 Open source Operating Cash Flow: 3310618 Open source Capital Expenditure: 2869204 Open source
20152015-12-31	Free cash flow margin	21.4%	Revenue: 27129609 Open source Operating Cash Flow: 5877213 Open source Capital Expenditure: 59475 Open source
20162016-12-31	Free cash flow margin	206%	Revenue: 2384492 Open source Operating Cash Flow: 4912665 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 4.9M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Operating cash flow	1310489	Operating Cash Flow: 1310489 Open source
20082008-12-31	Operating cash flow	2093206	Operating Cash Flow: 2093206 Open source
20092009-12-31	Operating cash flow	5673509	Operating Cash Flow: 5673509 Open source
20102010-12-31	Operating cash flow	12841432	Operating Cash Flow: 12841432 Open source
20112011-12-31	Operating cash flow	8773247	Operating Cash Flow: 8773247 Open source
20122012-12-31	Operating cash flow	-3583694	Operating Cash Flow: -3583694 Open source
20132013-12-31	Operating cash flow	8909113	Operating Cash Flow: 8909113 Open source
20142014-12-31	Operating cash flow	3310618	Operating Cash Flow: 3310618 Open source
20152015-12-31	Operating cash flow	5877213	Operating Cash Flow: 5877213 Open source
20162016-12-31	Operating cash flow	4912665	Operating Cash Flow: 4912665 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 4.9M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Free cash flow	1224150	Operating Cash Flow: 1310489 Open source Capital Expenditure: 86339 Open source
20082008-12-31	Free cash flow	2041436	Operating Cash Flow: 2093206 Open source Capital Expenditure: 51770 Open source
20092009-12-31	Free cash flow	5656948	Operating Cash Flow: 5673509 Open source Capital Expenditure: 16561 Open source
20102010-12-31	Free cash flow	11374946	Operating Cash Flow: 12841432 Open source Capital Expenditure: 1466486 Open source
20112011-12-31	Free cash flow	8662662	Operating Cash Flow: 8773247 Open source Capital Expenditure: 110585 Open source
20122012-12-31	Free cash flow	-3616564	Operating Cash Flow: -3583694 Open source Capital Expenditure: 32870 Open source
20132013-12-31	Free cash flow	7927101	Operating Cash Flow: 8909113 Open source Capital Expenditure: 982012 Open source
20142014-12-31	Free cash flow	441414	Operating Cash Flow: 3310618 Open source Capital Expenditure: 2869204 Open source
20152015-12-31	Free cash flow	5817738	Operating Cash Flow: 5877213 Open source Capital Expenditure: 59475 Open source
20162016-12-31	Free cash flow	4912665	Operating Cash Flow: 4912665 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

7.1% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2007-12-31	Liabilities / assets	Not reported	Total Assets: 20246679 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 28997806 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 47010469 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 68086943 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 83061876 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 70475300 Open source
20132013-12-31	Liabilities / assets	7.1%	Total Liabilities: 4791505 Open source Total Assets: 67564444 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 81247231 Open source
2015-12-31	Liabilities / assets	Not reported	Total Assets: 51363580 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 42502438 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.31× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Current assets / current liabilities	1.68×	Current Assets: 6635674 Open source Current Liabilities: 3955291 Open source
20082008-12-31	Current assets / current liabilities	2.23×	Current Assets: 12783655 Open source Current Liabilities: 5724701 Open source
20092009-12-31	Current assets / current liabilities	4.96×	Current Assets: 30221543 Open source Current Liabilities: 6090598 Open source
20102010-12-31	Current assets / current liabilities	5.71×	Current Assets: 43350234 Open source Current Liabilities: 7586946 Open source
20112011-12-31	Current assets / current liabilities	9.09×	Current Assets: 60508809 Open source Current Liabilities: 6660176 Open source
20122012-12-31	Current assets / current liabilities	3.3×	Current Assets: 41974131 Open source Current Liabilities: 12702552 Open source
20132013-12-31	Current assets / current liabilities	7.51×	Current Assets: 35985502 Open source Current Liabilities: 4791505 Open source
20142014-12-31	Current assets / current liabilities	4.9×	Current Assets: 43633047 Open source Current Liabilities: 8911880 Open source
20152015-12-31	Current assets / current liabilities	2.28×	Current Assets: 16167309 Open source Current Liabilities: 7098441 Open source
20162016-12-31	Current assets / current liabilities	1.31×	Current Assets: 7365124 Open source Current Liabilities: 5623261 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2007-01-01 – 2007-12-31	USD 3.96 million Exact value Exact value: 3963524 USD 2007-01-01 – 2007-12-31: 3963524 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2007-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 3963524 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3963524 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-09-000226.txt#12129 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1310489 USD 2007-01-01 – 2007-12-31: 1310489 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2007-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 1310489 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1310489 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-09-000226.txt#12310 The citation records this snapshot. The page link may show a newer release later.	USD 86,339 Exact value Exact value: 86339 USD 2007-01-01 – 2007-12-31: 86339 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2007-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 86339 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 86339 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-09-000226.txt#12350 The citation records this snapshot. The page link may show a newer release later.	USD 1.22 million Calculation and evidence 1310489 − 86339 USD Exact free cash flow: 1224150 USD 2007-01-01 – 2007-12-31: 1310489 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 86339 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2007-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 1224150 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1310489 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-09-000226.txt#12310 Input fundies:CapitalExpenditure: 86339 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-09-000226.txt#12350 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 6.69 million Exact value Exact value: 6690542 USD 2008-01-01 – 2008-12-31: 6690542 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2008-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 6690542 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6690542 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-10-000334.txt#13560 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Exact value Exact value: 2093206 USD 2008-01-01 – 2008-12-31: 2093206 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2008-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 2093206 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2093206 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-10-000334.txt#13728 The citation records this snapshot. The page link may show a newer release later.	USD 51,770 Exact value Exact value: 51770 USD 2008-01-01 – 2008-12-31: 51770 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2008-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 51770 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51770 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-10-000334.txt#13762 The citation records this snapshot. The page link may show a newer release later.	USD 2.04 million Calculation and evidence 2093206 − 51770 USD Exact free cash flow: 2041436 USD 2008-01-01 – 2008-12-31: 2093206 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 51770 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2008-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 2041436 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2093206 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-10-000334.txt#13728 Input fundies:CapitalExpenditure: 51770 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-10-000334.txt#13762 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 10.5 million Exact value Exact value: 10497840 USD 2009-01-01 – 2009-12-31: 10497840 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2009-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 10497840 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10497840 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-11-000366.txt#8550 The citation records this snapshot. The page link may show a newer release later.	USD 5.67 million Exact value Exact value: 5673509 USD 2009-01-01 – 2009-12-31: 5673509 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2009-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 5673509 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5673509 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-11-000366.txt#8718 The citation records this snapshot. The page link may show a newer release later.	USD 16,561 Exact value Exact value: 16561 USD 2009-01-01 – 2009-12-31: 16561 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2009-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 16561 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16561 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-11-000366.txt#8752 The citation records this snapshot. The page link may show a newer release later.	USD 5.66 million Calculation and evidence 5673509 − 16561 USD Exact free cash flow: 5656948 USD 2009-01-01 – 2009-12-31: 5673509 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 16561 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2009-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 5656948 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5673509 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-11-000366.txt#8718 Input fundies:CapitalExpenditure: 16561 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/0001185185-11-000366.txt#8752 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 17.38 million Exact value Exact value: 17381560 USD 2010-01-01 – 2010-12-31: 17381560 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2010-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 17381560 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 17381560 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518512000487/bspm-20111231.xml#26809 Filing: 000118518512000487 The citation records this snapshot. The page link may show a newer release later.	USD 12.84 million Exact value Exact value: 12841432 USD 2010-01-01 – 2010-12-31: 12841432 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2010-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 12841432 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12841432 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518512000487/bspm-20111231.xml#41877 Filing: 000118518512000487 The citation records this snapshot. The page link may show a newer release later.	USD 1.47 million Exact value Exact value: 1466486 USD 2010-01-01 – 2010-12-31: 1466486 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2010-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 1466486 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1466486 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518512000487/bspm-20111231.xml#42241 Filing: 000118518512000487 The citation records this snapshot. The page link may show a newer release later.	USD 11.37 million Calculation and evidence 12841432 − 1466486 USD Exact free cash flow: 11374946 USD 2010-01-01 – 2010-12-31: 12841432 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 1466486 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2010-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 11374946 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 12841432 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518512000487/bspm-20111231.xml#41877 Filing: 000118518512000487 Input fundies:CapitalExpenditure: 1466486 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518512000487/bspm-20111231.xml#42241 Filing: 000118518512000487 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 12.17 million Exact value Exact value: 12173513 USD 2011-01-01 – 2011-12-31: 12173513 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2011-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 12173513 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12173513 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518513000819/bspm-20121231.xml#94224 Filing: 000118518513000819 The citation records this snapshot. The page link may show a newer release later.	USD 8.77 million Exact value Exact value: 8773247 USD 2011-01-01 – 2011-12-31: 8773247 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2011-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 8773247 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8773247 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518513000819/bspm-20121231.xml#106465 Filing: 000118518513000819 The citation records this snapshot. The page link may show a newer release later.	USD 110,585 Exact value Exact value: 110585 USD 2011-01-01 – 2011-12-31: 110585 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2011-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 110585 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 110585 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518513000819/bspm-20121231.xml#106827 Filing: 000118518513000819 The citation records this snapshot. The page link may show a newer release later.	USD 8.66 million Calculation and evidence 8773247 − 110585 USD Exact free cash flow: 8662662 USD 2011-01-01 – 2011-12-31: 8773247 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 110585 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2011-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 8662662 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8773247 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518513000819/bspm-20121231.xml#106465 Filing: 000118518513000819 Input fundies:CapitalExpenditure: 110585 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518513000819/bspm-20121231.xml#106827 Filing: 000118518513000819 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 20 million Exact value Exact value: -19997323 USD 2012-01-01 – 2012-12-31: -19997323 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2012-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: -19997323 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19997323 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518514000771/bspm-20131231.xml#102523 Filing: 000118518514000771 The citation records this snapshot. The page link may show a newer release later.	−USD 3.58 million Exact value Exact value: -3583694 USD 2012-01-01 – 2012-12-31: -3583694 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2012-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: -3583694 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3583694 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518514000771/bspm-20131231.xml#117008 Filing: 000118518514000771 The citation records this snapshot. The page link may show a newer release later.	USD 32,870 Exact value Exact value: 32870 USD 2012-01-01 – 2012-12-31: 32870 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2012-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 32870 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 32870 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518514000771/bspm-20131231.xml#117372 Filing: 000118518514000771 The citation records this snapshot. The page link may show a newer release later.	−USD 3.62 million Calculation and evidence -3583694 − 32870 USD Exact free cash flow: -3616564 USD 2012-01-01 – 2012-12-31: -3583694 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 32870 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2012-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: -3616564 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3583694 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518514000771/bspm-20131231.xml#117008 Filing: 000118518514000771 Input fundies:CapitalExpenditure: 32870 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518514000771/bspm-20131231.xml#117372 Filing: 000118518514000771 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 809,046 Exact value Exact value: 809046 USD 2013-01-01 – 2013-12-31: 809046 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2013-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 809046 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 809046 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518515000919/bspm-20141231.xml#125144 Filing: 000118518515000919 The citation records this snapshot. The page link may show a newer release later.	USD 8.91 million Exact value Exact value: 8909113 USD 2013-01-01 – 2013-12-31: 8909113 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2013-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 8909113 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8909113 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518515000919/bspm-20141231.xml#141177 Filing: 000118518515000919 The citation records this snapshot. The page link may show a newer release later.	USD 982,012 Exact value Exact value: 982012 USD 2013-01-01 – 2013-12-31: 982012 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2013-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 982012 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 982012 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518515000919/bspm-20141231.xml#141541 Filing: 000118518515000919 The citation records this snapshot. The page link may show a newer release later.	USD 7.93 million Calculation and evidence 8909113 − 982012 USD Exact free cash flow: 7927101 USD 2013-01-01 – 2013-12-31: 8909113 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 982012 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2013-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 7927101 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8909113 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518515000919/bspm-20141231.xml#141177 Filing: 000118518515000919 Input fundies:CapitalExpenditure: 982012 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518515000919/bspm-20141231.xml#141541 Filing: 000118518515000919 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 4.85 million Exact value Exact value: 4848212 USD 2014-01-01 – 2014-12-31: 4848212 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2014-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: 4848212 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4848212 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518516004237/bspm-20151231.xml#108853 Filing: 000118518516004237 The citation records this snapshot. The page link may show a newer release later.	USD 3.31 million Exact value Exact value: 3310618 USD 2014-01-01 – 2014-12-31: 3310618 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2014-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 3310618 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3310618 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518516004237/bspm-20151231.xml#122420 Filing: 000118518516004237 The citation records this snapshot. The page link may show a newer release later.	USD 2.87 million Exact value Exact value: 2869204 USD 2014-01-01 – 2014-12-31: 2869204 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2014-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 2869204 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2869204 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518516004237/bspm-20151231.xml#122782 Filing: 000118518516004237 The citation records this snapshot. The page link may show a newer release later.	USD 441,414 Calculation and evidence 3310618 − 2869204 USD Exact free cash flow: 441414 USD 2014-01-01 – 2014-12-31: 3310618 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 2869204 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2014-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 441414 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3310618 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518516004237/bspm-20151231.xml#122420 Filing: 000118518516004237 Input fundies:CapitalExpenditure: 2869204 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518516004237/bspm-20151231.xml#122782 Filing: 000118518516004237 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 25.11 million Exact value Exact value: -25112562 USD 2015-01-01 – 2015-12-31: -25112562 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2015-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: -25112562 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25112562 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#127309 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.	USD 5.88 million Exact value Exact value: 5877213 USD 2015-01-01 – 2015-12-31: 5877213 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2015-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 5877213 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5877213 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138060 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.	USD 59,475 Exact value Exact value: 59475 USD 2015-01-01 – 2015-12-31: 59475 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2015-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 59475 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59475 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138418 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.	USD 5.82 million Calculation and evidence 5877213 − 59475 USD Exact free cash flow: 5817738 USD 2015-01-01 – 2015-12-31: 5877213 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 59475 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2015-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 5817738 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5877213 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138060 Filing: 000118518517000916 Input fundies:CapitalExpenditure: 59475 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138418 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 5.7 million Exact value Exact value: -5698385 USD 2016-01-01 – 2016-12-31: -5698385 USD Inspect Net Income Open source Share or cite Citation for Net Income · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Net Income: -5698385 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5698385 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#127184 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.	USD 4.91 million Exact value Exact value: 4912665 USD 2016-01-01 – 2016-12-31: 4912665 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Operating Cash Flow: 4912665 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4912665 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#137878 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138242 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.	USD 4.91 million Calculation and evidence 4912665 − 0 USD Exact free cash flow: 4912665 USD 2016-01-01 – 2016-12-31: 4912665 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Biostar Pharmaceuticals, Inc. · 2016-12-31 Biostar Pharmaceuticals, Inc. (edgar:1418133) Free cash flow: 4912665 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1418133?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4912665 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#137878 Filing: 000118518517000916 Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1418133/000118518517000916/bspm-20161231.xml#138242 Filing: 000118518517000916 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

41 filings · 2,202 latest values · 2,202 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001418133, 1418133, edgar:1418133

Also known as Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation